Compare TLX & OTTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TLX | OTTR |
|---|---|---|
| Founded | 2015 | 1907 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.7B |
| IPO Year | 2024 | 2009 |
| Metric | TLX | OTTR |
|---|---|---|
| Price | $10.79 | $88.56 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | $19.60 | ★ $90.50 |
| AVG Volume (30 Days) | ★ 469.9K | 173.1K |
| Earning Date | 10-15-2026 | 11-02-2026 |
| Dividend Yield | N/A | ★ 2.61% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.54 |
| Revenue | N/A | ★ $1,299,640,000.00 |
| Revenue This Year | $15.69 | $1.24 |
| Revenue Next Year | $13.80 | $2.48 |
| P/E Ratio | $150.33 | ★ $57.39 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.28 | $74.15 |
| 52 Week High | $13.11 | $95.09 |
| Indicator | TLX | OTTR |
|---|---|---|
| Relative Strength Index (RSI) | 43.29 | 48.60 |
| Support Level | $10.01 | $84.46 |
| Resistance Level | $11.48 | $90.45 |
| Average True Range (ATR) | 0.33 | 1.70 |
| MACD | -0.14 | 0.10 |
| Stochastic Oscillator | 3.37 | 55.01 |
Telix develops radiopharmaceuticals to manage cancer. Radiopharmaceuticals are radioisotopes bound to molecules that can target specific cells. At low doses, these drugs can bind to specific cancer cells with radiation, and then positron emission tomography imaging can accurately visualize tumors. At high doses, these drugs can selectively target and treat tumors with radiation, known as radioligand therapy. Radiopharmaceuticals are usually injected into the bloodstream. Telix has a pipeline of potential radiopharmaceuticals but currently earns most of its revenue from US sales of Illuccix, largely used as an imaging agent to visualize the spread of prostate cancer.
Otter Tail Corp is a U.S. energy company that operates in the electric (produces and sells electricity), manufacturing (fabricates metal components), and plastics segments (pipes for water uses). The company conducts its operations and acquires the majority of its revenue in the U.S. in the states of Minnesota, South Dakota, and North Dakota. The majority of the company's revenue is derived from the Electric segment and commercial customers, although it generates revenue from residential and industrial customers, as well.